课题基金 / 基金详情

项目摘要

项目成果

Anna L Malkova的其他基金

相似基金

相关文献

中文摘要
翻译
维持遗传稳定性对于细胞和生物体的生存至关重要。双链 DNA 断裂 (DSB) 是威胁基因组稳定性的最致命的 DNA 损伤,细胞已经进化出一种 多种修复机制。虽然一些修复机制是准确的,但另一些则存在“风险” 并可能进一步破坏基因组的稳定性,导致人类癌症和其他疾病。分子 将原本准确的修复途径的中间体拖入不稳定“漩涡”的事件 DNA 修复机制,然后通过危险的 DNA 修复途径处理这些中间体, 仍未被探索。我们研究的目标是了解 DSB 修复如何转化为有害物质 修复途径,特别强调三种 DSB 修复现象:1)断裂诱导复制(BIR), 一种不寻常的长链修复 DNA 合成,可促进遗传不稳定性的爆发; 2) 微同源介导的 BIR (MMBIR),一种涉及多个模板切换事件的复制途径 产生复杂基因组重排的微同源性位置; 3)长的转变 DSB 的单链 DNA 中间体修复成“有毒”联合分子,促进细胞死亡。作为起始 一点,我们在酵母中使用我们可靠且强大的系统,其中单个 DSB 由一个位点启动- 特异性 H2O 核酸内切酶;我们已经证明,所有三个感兴趣的修复事件都可以用于 修复该系统中的损伤。使用该系统获得的知识——修复机制, 中间体、参与蛋白质和突变模式——用于为实验设计提供信息 将评估其他酵母和哺乳动物系统中的这些途径的研究。从概念上讲,长期 各个项目的目标都是相同的,并且涉及三个主要的探究领域。首先,利用敏感的基因 方法、蛋白质和 DNA 基序的存在影响修复中间体进入 破坏稳定的修复机制的“漩涡”将会被识别出来。二、体内与体外相结合 方法将用于建模和研究细胞的决策点以了解情况 (结构、动力学、参与蛋白质等)将中间体引入高风险和/或有毒修复 途径。第三,有害物质引起的突变和染色体重排的模式 将评估修复途径,并使用计算方法将这些发现应用于 人类基因组数据库。为此,根据之前的研究开发的新软件 MMBIRFinder 将 可用于检测当前可用算法无法发现的复杂遗传变化。总体而言,这 研究计划将提高 DNA 修复中间加工机制的清晰度, 这将揭示影响危险修复途径调节的因素并导致 真核生物基因组的不稳定。
英文摘要
Maintaining genetic stability is of paramount importance for the survival of cells and organisms. Double-strand DNA breaks (DSBs) are the most lethal DNA lesion threatening genomic stability, and cells have evolved a variety of mechanisms for their repair. While some of the repair mechanisms are accurate, others are “risky” and can further destabilize the genome, leading to cancer and other diseases in humans. The molecular events that draw the intermediates of otherwise accurate repair pathways into a “maelstrom” of destabilizing DNA repair mechanisms, where these intermediates are then processed through risky DNA repair pathways, remain unexplored. The goal of our research is to understand how DSB repair is channeled into the deleterious repair pathways, with particular emphasis on three DSB repair phenomena: 1) break-induced replication (BIR), an unusual type of long-tract repair DNA synthesis that promotes bursts of genetic instabilities; 2) microhomology-mediated BIR (MMBIR), a replicative pathway involving multiple template switching events at positions of microhomologies that yields complex genomic rearrangements; and 3) the transformation of long single-strand DNA intermediates of DSB repair into “toxic” joint molecules promoting cell death. As a starting point, we are using our dependable and powerful system in yeast, where a single DSB is initiated by a site- specific HO endonuclease; we have demonstrated that all three of the repair events of interest can be used to repair the lesion in this system. The knowledge obtained using this system – the repair mechanisms, intermediates, participating proteins, and mutation patterns – is used to inform the experimental design of studies that will evaluate these pathways in other yeast and mammalian systems. Conceptually, the long-term goals are the same across projects and involve three primary areas of inquiry. First, using sensitive genetic approaches, proteins and DNA motifs whose presence affect the funneling of the repair intermediates into the “maelstrom” of destabilizing repair mechanisms will be identified. Second, a combination of in vivo and in vitro approaches will be used to model and investigate the cell's decision points to understand the circumstances (structures, kinetics, participating proteins, etc.) that draw intermediates into high-risk and/or toxic repair pathways. Third, the patterns of mutations and chromosomal rearrangements that result from the deleterious repair pathways will be evaluated, and computational approaches will be used to apply these findings to human genome databases. To this end, MMBIRFinder, new software developed from previous research, will be used to detect complex genetic changes that cannot be found by currently available algorithms. Overall, this research program will bring improved clarity regarding the mechanisms of DNA repair intermediate processing, which will uncover factors that influence the regulation of dangerous repair pathways and result in destabilization of the genome in eukaryotes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of human RAD52 protein in genome stability
  • 批准号:
    9763870
  • 项目类别:
  • 资助金额:
    $41.18万
  • 财政年份:
    2019
  • 负责人:
    Anna L Malkova
  • 依托单位:
The role of human RAD52 protein in genome stability
  • 批准号:
    9904590
  • 项目类别:
  • 资助金额:
    $41.85万
  • 财政年份:
    2019
  • 负责人:
    Anna L Malkova
  • 依托单位:
The role of human RAD52 protein in genome stability
  • 批准号:
    10361559
  • 项目类别:
  • 资助金额:
    $40.0万
  • 财政年份:
    2019
  • 负责人:
    Anna L Malkova
  • 依托单位:
The role of human RAD52 protein in genome stability
  • 批准号:
    10582621
  • 项目类别:
  • 资助金额:
    $39.91万
  • 财政年份:
    2019
  • 负责人:
    Anna L Malkova
  • 依托单位:
海外基金